PDSB Award Disclosure
Dawson John Andrew · SEC Form 4 · Filed Oct 21, 2026
Award
Calculated transaction value
$0
Dawson John Andrew Director
Transaction date
Oct 18, 2026
Public filing date
Oct 21, 2026
Filing lag
Filed 3 days later
PDSB daily price context
Close on/before transaction
$1.13
Oct 16, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 22,700 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001140361-26-040424
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Pds Biotechnology Corp PDSB Current | Award | Oct 18, 2026 | $0 |